Recent News

  1. JDI releases a patient video to demystify the role of Radioactive Iodine in the treatment of Differentiated Thyroid Cancer (DTC) Jubilant DraxImage is pleased to announce the launch of its first video series focused on one of the fastest growing cancers in North America: thyroid cancer. The production of this (...)
  2. Jubilant DraxImage signs Term Sheet with Cyclopharm for exclusive license to market Technegas in the United States Montreal & Sydney, September 14, 2015 – Jubilant DraxImage Inc. (“DraxImage”) and Cyclopharm Limited (“CYC”) are pleased to announce the signing of a term sheet, subject to satisfactory due diligence and  execution of (...)
  3. JDI supports Thyroid Cancer Canada and Thyroid Cancer Survivors’ Association (US) in their educational endeavour… Jubilant DraxImage is thrilled to host Thyroid Cancer survivors, representatives of these organizations, as well as a world renowned expert in the field of radioiodine ablation therapy. A big welcome goes to Marie-Hélène Caron, Jennifer (...)
  4. Come meet us and listen to fireside chats between KOLs and Dr. Norman LaFrance Come meet us and listen to fireside chats between KOLs and Dr. Norman LaFrance throughout the conference about cardiac PET imaging and its promise to improve patient care. For more information, see the schedule at the booth. (...)
  5. We are pleased to announce the hiring of Mr. James Lalli, as Endocrine Brand Portfolio Manager, as of July 6th, 2015. In his new role, James will be responsible for the lifecycle management of iodine-131 diagnostic and therapeutic, HICON®, SMART-FILLTM, and MIBG. James will be reporting to Suzanne Bissonnette and (...)
  6. Come meet us and attend mini-presentations from SNMMI fellows and get your copy of the History of SNMMI. Jubilant DraxImage will be pleased to meet you at booth 853. We will host several mini-presentations on important topics such as Resurgence of V/Q imaging for PE and Importance of RAI in (...)
  7. Due to the planned maintenance shutdown of the RNU reactor, a Xenon-133 shortage is estimated to last until May 25th. COMMUNICATION: Use of Tc-99m DTPA in Lung Ventilation during Xe-133 supply shortage Dear Valued Jubilant DraxImage Customer, As you are aware, due to the planned maintenance shutdown of the Canadian (...)
  8. Jubilant DraxImage, Inc., a Jubilant Pharma Company, announced today that it filed a citizen petition on April 20, 2015 with the United States federal Food and Drug Administration (FDA) under docket number FDA-2015-p-1296 at Web link to Docket Number# http://www.regulations.gov/#!documentDetail;D=FDA-2015-P-1296-0001. The citizen petition is a mechanism used to request, among other things, that (...)
  9. We are pleased to announce the hiring of Mr. Daniel Herrera, as Lung Imaging Portfolio Manager, as of December 8th 2014 We are pleased to announce the hiring of Mr. Daniel Herrera, as Lung Imaging Portfolio Manager, as of December 8th 2014. In his new role, Daniel will be responsible for the Global (...)
  10. Some members of the Jubilant DraxImage Management Team will be attending the upcoming RSNA 2015 from Decebemr 1st to December 3rd in Chicago, IL.
  11. We are pleased to announce the hiring of Mrs. Valérie Gilbert We are pleased to announce the hiring of Mrs. Valérie Gilbert, as Director, Manufacturing Operations effective October 20th2014. In her new role, Valérie will be responsible for production, validation, technical services and supply chain departments.  In our matrix structure, Valerie will (...)
  12. Jubilant DraxImage demonstrated innovation by displaying a holographic presentation at their booth, a first in the industry and a first at a medical meeting. ASNC 2014, Boston, MA Jubilant DraxImage demonstrated innovation by displaying a holographic presentation at their booth, a first in the industry and a first at a (...)
  13. Celia Correa: her expertise in navigating the complexities of international markets will be a great addition to JDI. Ms. Correa will lead Jubilant DraxImage – Latin America growth plan. Jubilant DraxImage Inc., a Jubilant Pharma company, is pleased to announce the appointment of Ms. Celia Correa to the position of (...)
  14. Each year, more than three million patients in North America find themselves up against a deadly foe – pulmonary embolism (PE) – and without early detection and diagnosis; many patients will lose their lives. However, Lung Ventilation and Perfusion (V/Q) scanning, an advanced imaging procedure, has proven to be essential (...)